333
Views
17
CrossRef citations to date
0
Altmetric
Epidemiology

Epidemiological and clinical features of amyotrophic lateral sclerosis in a Tunisian cohort

, , , , , & show all
Pages 131-139 | Received 03 Jun 2019, Accepted 05 Dec 2019, Published online: 20 Dec 2019

References

  • Beghi E, Logroscino G, Chiò A, Hardiman O, Mitchell D, Swingler R, et al. The epidemiology of ALS and the role of population-based registries. Biochim Biophys Acta. 2006;1762:1150–7.
  • Hoppitt T, Pall H, Calvert M, Gill P, Yao G, Ramsay J, et al. A systematic review of the incidence and prevalence of long-term neurological conditions in the UK. Neuroepidemiology. 2011;36:19–28.
  • Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W, et al. Amyotrophic lateral sclerosis. Nat Rev Dis Primers. 2017;3:17071.
  • Chiò A, Mora G, Calvo A, Mazzini L, Bottacchi E, Mutani R. Epidemiology of ALS in Italy: a 10-year prospective population-based study. Neurology. 2009;72:725–31.
  • Mitchell JD, Borasio GD. Amyotrophic lateral sclerosis. Lancet. 2007;369:2031–41.
  • Couratier P, Corcia P, Lautrette G, Nicol M, Preux PM, Marin B. Epidemiology of amyotrophic lateral sclerosis: a review of literature. Rev Neurol. 2016;172:37–45.
  • Beghi E, Chiò A, Couratier P, Esteban J, Hardiman O, Logroscino G, et al. The epidemiology and treatment of ALS: focus on the heterogeneity of the disease and critical appraisal of therapeutic trials. Amyotroph Lateral Scler. 2011;12:1–10.
  • Marin B, Boumédiene F, Logroscino G, Couratier P, Babron MC, Leutenegger AL, et al. Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis. Int J Epidemiol. 2017;46:57–74.
  • Pradas J, Puig T, Rojas-García R, Viguera ML, Gich I, Logroscino G; ALS-CAT Group. Amyotrophic lateral sclerosis in Catalonia: a population based study. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14:278–83.
  • Jun KY, Park J, Oh KW, Kim EM, Bae JS, Kim I, et al. Epidemiology of ALS in Korea using nationwide big data. J Neurol Neurosurg Psychiatry. 2019;90:395–403.
  • Luna J, Logroscino G, Couratier P, Marin B. Current issues in ALS epidemiology: variation of ALS occurrence between populations and physical activity as a risk factor. Rev Neurol. 2017;173:244–53.
  • Talbott EO, Malek AM, Lacomis D. The epidemiology of amyotrophic lateral sclerosis. Handb Clin Neurol. 2016;138:225–38.
  • Logroscino G, Traynor BJ, Hardiman O, Chiò, A, Mitchell D, Swingler RJ, et al. Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry. 2010;81:385–90.
  • Zaldivar T, Gutierrez J, Lara G, Carbonara M, Logroscino G, Hardiman O. Reduced frequency of ALS in an ethnically mixed population: a population-based mortality study. Neurology. 2009;72:1640–5.
  • Logroscino G, Piccininni M, Marin B, Nichols E, Abd-Allah F, Abdelalim A, et al. Global, regional, and national burden of motor neuron diseases 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17:1083–97.
  • Marin B, Kacem I, Diagana M, Boulesteix M, Gouider R, Preux PM, et al. Juvenile and adult-onset ALS/MND among Africans: incidence, phenotype, survival: a review. Amyotroph Lateral Scler. 2012;13:276–83.
  • Ben Hamida M, Hentati F. Maladie de Charcot et sclérose latérale amyotrophique juvénile. Rev Neurol 1984;140:202–6.
  • Statistics Tunisia, National Institute of Statistics. data portal. Social and demography, population branch; 2018 July [accessed 2018 November 17]. http://www.ins.tn/en/themes/population.
  • Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–9.
  • Byrne S, Bede P, Elamin M, Kenna K, Lynch C, McLaughlin R, et al. Proposed criteria for familial amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2011;12:157–9.
  • Halim NB, Bouafif NBA, Romdhane L, Atig RKB, Chouchane I, Bouyacoub Y, et al. Consanguinity, endogamy, and genetic disorders in Tunisia. J Community Genet. 2013;4:273–84.
  • Atassi N, Berry J, Shui A, Zach N, Sherman A, Sinani E, et al. The PRO ACT database: design, initial analyses, and predictive features. Neurology. 2014;83:1719–25.
  • General Assembly of the World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. J Am Coll Dent. 2014;81:14–8.
  • Logroscino G, Beghi E, Zoccolella S, Palagano R, Fraddosio A, Simone IL, et al. Incidence of amyotrophic lateral sclerosis in southern Italy: a population based study. Journal of Neurology. Neurosurg Psychiatry. 2005;76:1094–8.
  • Logroscino G, Traynor BJ, Hardiman O, Chio' A, Couratier P, Mitchell JD, et al. Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues. J Neurol Neurosurg Psychiatry. 2008;79:6–11.
  • Marin B, Gil J, Preux PM, Funalot B, Couratier P. Incidence of amyotrophic lateral sclerosis in the Limousin region of France, 1997–2007. Amyotroph Lateral Scler. 2009;10:216–20.
  • Scialo C, Novi G, Bandettini di Poggio M, Canosa A, Sormani MP, Mandich P, et al. Clinical epidemiology of amyotrophic lateral sclerosis in Liguria, Italy: an update of LIGALS register. Amyotroph Lateral Scler Frontotemporal Degener. 2016;17:535–42.
  • Fong KY, Yu YL, Chan YW, Kay R, Chan J, Yang Z, et al. Motor neuron disease in Hong Kong Chinese: epidemiology and clinical picture. Neuroepidemiology. 1996;15:239–45.
  • Armon C. An evidence-based medicine approach to the evaluation of the role of exogenous risk factors in sporadic amyotrophic lateral sclerosis. Neuroepidemiology. 2003;22:217–28.
  • Armon C. Smoking may be considered an established risk factor for sporadic ALS. Neurology. 2009;73:1693–8.
  • Al-Chalabi A, Hardiman O. The epidemiology of ALS: a conspiracy of genes, environment and time. Nat Rev Neurol. 2013;9:617.
  • Logroscino G, Piccininni M. Amyotrophic lateral sclerosis descriptive epidemiology: the origin of geographic difference. Neuroepidemiology. 2019;52:93–103.
  • Riggs JE. Amyotrophic lateral sclerosis, heterogeneous susceptibility, trauma, and epidemiology. Arch Neurol. 1996;53:225–7.
  • Radhakrishnan K, Ashok PP, Sridharan R, Mousa ME. Descriptive epidemiology of motor neuron disease in Benghazi, Libya. Neuroepidemiology. 1986;5:47–54.
  • Imounan F, Lahbouje S, Hsaini Y, Regragui W, Ben Haddou EA, Benomar A, et al. Aspects cliniques et environnementaux de la sclérose latérale amyotrophique chez une population marocaine: étude de 60 cas. Tunisie Médicale. 2015;93:365–70.
  • Bener A, Mohammad RR. Global distribution of consanguinity and their impact on complex diseases: genetic disorders from an endogamous population. Egypt J Med Hum Genet. 2017;18:315–20.
  • Vallat JM, Tazir M, Magdelaine C, Sturtz F, Grid D. Autosomal-recessive Charcot-Marie-Tooth diseases. J Neuropathol Exp Neurol. 2005;64:363–70.
  • Tadmouri GO, Nair P, Obeid T, Al Ali MT, Al Khaja N, Hamamy HA. Consanguinity and reproductive health among Arabs. Reprod Health. 2009;6:17.
  • O’Toole O, Traynor BJ, Brennan P, Sheehan C, Frost E, Corr B, et al. Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004. J Neurol Neurosurg Psychiatry. 2008;79:30–2.
  • Georgoulopoulou E, Vinceti M, Bonvicini F, Sola P, Goldoni CA, Girolamo GD, et al. Changing incidence and subtypes of ALS in Modena, Italy: a 10-years prospective study. Amyotroph Lateral Scler. 2011;12:451–7.
  • Özoğuz A, Uyan Ö, Birdal G, Iskender C, Kartal E, Lahut S, et al. The distinct genetic pattern of ALS in Turkey and novel mutations. Neurobiol Aging. 2015;36:1764–e9.
  • Stevic Z, Kostic-Dedic S, Peric S, Dedic V, Basta I, Rakocevic-Stojanovic V, et al. Prognostic factors and survival of ALS patients from Belgrade, Serbia. Amyotroph Lateral Scler Frontotemporal Degener. 2016;17:508–14.
  • Liu X, He J, Gao FB, Gitler AD, Fan D. The epidemiology and genetics of Amyotrophic lateral sclerosis in China. Brain Res. 2018;1693:121–6.
  • McCombe PA, Henderson RD. Effects of gender in amyotrophic lateral sclerosis. Gend Med. 2010;7:557–70.
  • Pugliatti M, Parish LD, Cossu P, Leoni S, Ticca A, Saddi MV, et al. Amyotrophic lateral sclerosis in Sardinia, insular Italy, 1995–2009. J Neurol. 2013;260:572–9.
  • Palese F, Sartori A, Logroscino G, Pisa FE. Predictors of diagnostic delay in amyotrophic lateral sclerosis: a cohort study based on administrative and electronic medical records data. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20:176–85.
  • Galvin M, Ryan P, Maguire S, Heverin M, Madden C, Vajda A, et al. The path to specialist multidisciplinary care in amyotrophic lateral sclerosis: a population-based study of consultations, interventions and costs. PloS One. 2017;12:e0179796.
  • Beghi E, Millul A, Micheli A, Vitelli E, Logroscino G. Incidence of ALS in Lombardy, Italy. Neurology. 2007;68:141–5.
  • Pegoraro V, Merico A, Angelini C. Micro-RNAs in ALS muscle: differences in gender, age at onset and disease duration. J Neurol Sci. 2017;380:58–63.
  • Brown RH, Al-Chalabi A. Amyotrophic lateral sclerosis. N Engl J Med. 2017;377:162–72.
  • Byrne S, Walsh C, Lynch C, Bede P, Elamin M, Kenna K, et al. Rate of familial amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2011;82:623–7.
  • Luna J, Diagana M, Aissa LA, Tazir M, Pacha LA, Kacem I, et al. Clinical features and prognosis of amyotrophic lateral sclerosis in Africa: the TROPALS study. J Neurol Neurosurg Psychiatry. 2019;90:20–9.
  • Caroscio JT, Mulvihill MN, Sterling R, Abrams B. Amyotrophic lateral sclerosis: its natural history. Neurol Clin. 1987;5:1–8.
  • Piquemal M, Beugre K, Boa YF, Giordano C. Etude clinique de 30 observations de syndrome de sclérose latérale amyotrophique observés en Côte d’Ivoire. Afr J Neurol Sci. 1982;1:31–40.
  • Ndiaye IP, Ndiaye M, Gueye M, Ndiaye MB. 1986. Les maladies dégénératives de la moelle. Congress of the Pan African Association of Neurological Sciences. Abidjan (Côte d’Ivoire)
  • Bougteba A, Basir A, Birouk N, Belaidi H, Kably B, Ouazzani R, et al. Etude de 276 cas. Journée de Neurologie de Langue Française. Rev Neurol (Paris). 2005;161:S97.
  • Creemers H, Grupstra H, Nollet F, van den Berg LH, Beelen A. Prognostic factors for the course of functional status of patients with ALS: a systematic review. J Neurol. 2015;262:1407–23.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.